New insights of propolis nanoformulation and its therapeutic potential in human diseases

Background and purpose: Scientific research is crucial to develop therapies for various disease severity levels, as modern drugs cause side effects and are difficult to predict. Researchers are exploring herbal alternatives with fewer side effects, particularly propolis, which has been validated th...

Full description

Bibliographic Details
Main Authors: Paula Mariana Kustiawan, Putri Hawa Syaifie, Khalish Arsy Al Khairy Siregar, Delfritama Ibadillah, Etik Mardliyati
Format: Article
Language:English
Published: International Association of Physical Chemists (IAPC) 2024-01-01
Series:ADMET and DMPK
Subjects:
Online Access:https://pub.iapchem.org/ojs/index.php/admet/article/view/2128
_version_ 1797342320506437632
author Paula Mariana Kustiawan
Putri Hawa Syaifie
Khalish Arsy Al Khairy Siregar
Delfritama Ibadillah
Etik Mardliyati
author_facet Paula Mariana Kustiawan
Putri Hawa Syaifie
Khalish Arsy Al Khairy Siregar
Delfritama Ibadillah
Etik Mardliyati
author_sort Paula Mariana Kustiawan
collection DOAJ
description Background and purpose: Scientific research is crucial to develop therapies for various disease severity levels, as modern drugs cause side effects and are difficult to predict. Researchers are exploring herbal alternatives with fewer side effects, particularly propolis, which has been validated through in vitro, in vivo, and clinical studies. This will focus on scientific evidence and its supporting technology for developing new bioactive compounds for chronic diseases. Nanotechnology can improve the delivery and absorption of herbal medicines, which often have poor bioavailability due to their high molecular weight and solubility in water, particularly in oral medicines. This technology can enhance propolis's effects through multi-target therapy and reduce side effects. Experimental approach: All publications related to each section of this review were discovered using the search engines Google Scholar, Scopus, and Pubmed. This was only available for publication between 2013 and 2023. The selected publications were used as references in this review after being thoroughly studied. Key results: Evaluation of propolis active compounds, the classification of propolis nano formulations, design concepts, and mechanisms of action of propolis nano formulation. Additionally, the challenges and prospects for how these insights can be translated into clinical benefits are discussed. Conclusion: In the last ten years, a list of nanoformulation propolis has been reported. This review concludes the difficulties encountered in developing large-scale nanoformulations. To commercialize them, improvements in nano carrier synthesis, standardized evaluation methodology within the framework of strategy process improvement, and Good Manufacturing Practices would be required.
first_indexed 2024-03-08T10:31:34Z
format Article
id doaj.art-8bdaabf95e694d4cbcddacd41ede0571
institution Directory Open Access Journal
issn 1848-7718
language English
last_indexed 2024-03-08T10:31:34Z
publishDate 2024-01-01
publisher International Association of Physical Chemists (IAPC)
record_format Article
series ADMET and DMPK
spelling doaj.art-8bdaabf95e694d4cbcddacd41ede05712024-01-27T02:23:01ZengInternational Association of Physical Chemists (IAPC)ADMET and DMPK1848-77182024-01-0110.5599/admet.2128New insights of propolis nanoformulation and its therapeutic potential in human diseasesPaula Mariana Kustiawan0Putri Hawa Syaifie1Khalish Arsy Al Khairy Siregar2Delfritama Ibadillah3Etik Mardliyati4Faculty of Pharmacy, Universitas Muhammadiyah Kalimantan Timur, Samarinda, East Kalimantan 75124, IndonesiaCenter of Excellence Life Sciences, Nano Center Indonesia, South Tangerang 15314, IndonesiaFaculty of Pharmacy, Universitas Muhammadiyah Kalimantan Timur, Samarinda, East Kalimantan 75124, Indonesia and Center of Excellence Life Sciences, Nano Center Indonesia, South Tangerang 15314, IndonesiaCenter of Excellence Life Sciences, Nano Center Indonesia, South Tangerang 15314, IndonesiaResearch Center for Vaccine and Drug, National Research and Innovation Agency (BRIN), Bogor 16911, Indonesia Background and purpose: Scientific research is crucial to develop therapies for various disease severity levels, as modern drugs cause side effects and are difficult to predict. Researchers are exploring herbal alternatives with fewer side effects, particularly propolis, which has been validated through in vitro, in vivo, and clinical studies. This will focus on scientific evidence and its supporting technology for developing new bioactive compounds for chronic diseases. Nanotechnology can improve the delivery and absorption of herbal medicines, which often have poor bioavailability due to their high molecular weight and solubility in water, particularly in oral medicines. This technology can enhance propolis's effects through multi-target therapy and reduce side effects. Experimental approach: All publications related to each section of this review were discovered using the search engines Google Scholar, Scopus, and Pubmed. This was only available for publication between 2013 and 2023. The selected publications were used as references in this review after being thoroughly studied. Key results: Evaluation of propolis active compounds, the classification of propolis nano formulations, design concepts, and mechanisms of action of propolis nano formulation. Additionally, the challenges and prospects for how these insights can be translated into clinical benefits are discussed. Conclusion: In the last ten years, a list of nanoformulation propolis has been reported. This review concludes the difficulties encountered in developing large-scale nanoformulations. To commercialize them, improvements in nano carrier synthesis, standardized evaluation methodology within the framework of strategy process improvement, and Good Manufacturing Practices would be required. https://pub.iapchem.org/ojs/index.php/admet/article/view/2128nanomaterialnanopropolispharmacological action
spellingShingle Paula Mariana Kustiawan
Putri Hawa Syaifie
Khalish Arsy Al Khairy Siregar
Delfritama Ibadillah
Etik Mardliyati
New insights of propolis nanoformulation and its therapeutic potential in human diseases
ADMET and DMPK
nanomaterial
nanopropolis
pharmacological action
title New insights of propolis nanoformulation and its therapeutic potential in human diseases
title_full New insights of propolis nanoformulation and its therapeutic potential in human diseases
title_fullStr New insights of propolis nanoformulation and its therapeutic potential in human diseases
title_full_unstemmed New insights of propolis nanoformulation and its therapeutic potential in human diseases
title_short New insights of propolis nanoformulation and its therapeutic potential in human diseases
title_sort new insights of propolis nanoformulation and its therapeutic potential in human diseases
topic nanomaterial
nanopropolis
pharmacological action
url https://pub.iapchem.org/ojs/index.php/admet/article/view/2128
work_keys_str_mv AT paulamarianakustiawan newinsightsofpropolisnanoformulationanditstherapeuticpotentialinhumandiseases
AT putrihawasyaifie newinsightsofpropolisnanoformulationanditstherapeuticpotentialinhumandiseases
AT khalisharsyalkhairysiregar newinsightsofpropolisnanoformulationanditstherapeuticpotentialinhumandiseases
AT delfritamaibadillah newinsightsofpropolisnanoformulationanditstherapeuticpotentialinhumandiseases
AT etikmardliyati newinsightsofpropolisnanoformulationanditstherapeuticpotentialinhumandiseases